Valbenazine ( DrugBank: Valbenazine )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	2

8. ハンチントン病

---

臨床試験数 : 229 /  薬物数 : 193 - (DrugBank : 60) / 標的遺伝子数 : 84 - 標的パスウェイ数 : 158

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04400331 (ClinicalTrials.gov)	September 18, 2020	19/5/2020	Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease	Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease	Chorea, Huntington	Drug: Valbenazine	Neurocrine Biosciences	Huntington Study Group	Recruiting	18 Years	75 Years	All	150	Phase 3	United States;Canada
2	NCT04102579 (ClinicalTrials.gov)	November 13, 2019	23/9/2019	Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease	Chorea, Huntington	Drug: Valbenazine;Drug: Placebo	Neurocrine Biosciences	Huntington Study Group	Completed	18 Years	75 Years	All	128	Phase 3	United States;Canada